Prophylactic application of levosimendan in cardiac surgical patients with severe left ventricle dysfunction

Experimental and Clinical Cardiology

Volumn 14, Issue 2, 2009, Pages

  Brezina, Ales ^a   Riha, Hynek ^a   Pirk, Jan ^a  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

EuroSCORE; High risk cardiac surgery; Inotropic drugs; Left ventricle dysfunction; Levosimendan

Indexed keywords

ATRACURIUM; COROTROP; DOBUTAMIN LACHEMA; DOBUTAMINE; KETOPROFEN; LEVOSIMENDAN; MIDAZOLAM; MILRINONE; MORPHINE; NORADRENALIN; OXYGEN; PANCURONIUM; SEVOFLURANE; SUFENTANIL; UNCLASSIFIED DRUG;

ADULT; AGED; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENERAL ANESTHESIA; HEART HEMODYNAMICS; HEART INDEX; HEART LEFT VENTRICLE FAILURE; HEART PERFORMANCE; HEART SURGERY; HIGH RISK PATIENT; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LOW DRUG DOSE; MALE; OBSERVATIONAL STUDY; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURGICAL PATIENT; TREATMENT OUTCOME;

EID: 70350593994     PISSN: 12056626     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Figgitt DP, Gillies PS, Goa KL. Levosimendan. Drugs 2001;61:613-627
2. ATP channel opener. Eur J Pharmacol 2001;428:311-314
3. Sonntag S, Sundberg S, Lehtonen LA, et al. The calcium sensitizer levosimendan improves the function of stunned myocardium after percutaneous transluminal coronary angiography in acute myocardial ischemia. J Am Coll Cardiol 2004;43:2177-2182 (Pubitemid 38757582)
4. Toller WG, Stranz C. Levosimendan, a new intropic and vasodilator agent. Anesthesiology 2006;104:556-569
5. Raja SG, Rayen BS. Levosimendan in cardiac surgery: Current best available evidence. Ann Thorac Surg 2006;81:1536-1546
6. Tritapepe L, De Santis V, Vitale D, et al. Preconditioning effects of levosimendan in coronary artery bypass grafting - pilot study. Br J Anaesth 2006;96:694-700. (Pubitemid 43786683)
7. Kivikko M, Antila S, Eha J, et al. Pharmacodynamics and safety of a new calcium sensitizer, levosimendan, and its metabolites during an extended infusion in patients with severe heart failure. J Clin Pharmacol 2002;42:43-51. (Pubitemid 34038369)
8. Lehmann A, Lang J, Boldt J, et al. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: A case series. Med Sci Monit 2004;10:MT89-93. (Pubitemid 39166442)
9. Alvarez J, Bouzada M, Fernandez AL, et al. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 2006;59:338-345 (Pubitemid 43833838)
10. De Hert SG, Lorsomradee S, Cromheecke S, et al. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anest Analg 2007;104:766-773 (Pubitemid 46548294)
11. Lehmann A, Kiessling A-H, Isgro F, et al. Levosimendan in patients with acute myocardial ischaemia undergoing emergency surgical revascularization. Eur J Anaesthesiol 2008;25:224-229 (Pubitemid 351170384)
12. De Hert SG, Lorsomradee S, vanden Eede H, et al. A randomized trial evaluating different modalities of levosimendan administration in cadiac surgery patients with myocardial dysfunction. J Cardiothorac Vasc Anesth 2008;22:699-705.
13. Jarvela K, Maaranen P, Sisto T, Ruokonen E. Levosimendan in aortic valve surgery: Cardiac performance and recovery. J Cardiothorac Vasc Anesth 2008;22:693-698